Scarica l'app Stockscreener
16.80
2.56%
0.42
Dopo l'orario di chiusura:
16.82
0.02
+0.12%
Precedente Chiudi:
$16.38
Aprire:
$16.475
Volume 24 ore:
116.47K
Relative Volume:
0.76
Capitalizzazione di mercato:
$246.59M
Reddito:
-
Utile/perdita netta:
$-21.76M
Rapporto P/E:
-10.85
EPS:
-1.5479
Flusso di cassa netto:
$-12.78M
1 W Prestazione:
+16.99%
1M Prestazione:
-11.63%
6M Prestazione:
-37.43%
1 anno Prestazione:
+39.07%
Intervallo 1D:
$15.96
$17.42
Intervallo di 1 settimana:
$14.76
$17.74
Portata 52W:
$7.78
$34.10
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
Nome
Greenwich Lifesciences Inc
Settore
Industria
Telefono
203-434-3290
Indirizzo
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Compare GLSI vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
16.80 | 248.36M | 0 | -21.76M | -12.78M | -1.5479 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Iniziato | Noble Capital Markets | Outperform |
| 2021-09-01 | Iniziato | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc Borsa (GLSI) Ultime notizie
Why Did GLSI Stock Rise Pre-Market Today? - Stocktwits
What’s Driving GLSI Stock Today? - Stocktwits
Greenwich Lifesciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results - marketbeat.com
Greenwich LifeSciences 2Q 2026: Revenue $0 Net loss $(3.95M), EPS $(0.27) — 10-Q Summary - TradingView
Greenwich LifeSciences, Inc. (GLSI) stock price, news, quote and history - Yahoo Finance Singapore
Greenwich Lifesciences Inc expected to post a loss of 33 cents a shareEarnings Preview - TradingView
Responsive Playbooks and the GLSI Inflection - Stock Traders Daily
Greenwich LifeSciences Extends Insider and Pre-IPO Share Lock-Up to January 31, 2027 - quiverquant.com
Greenwich LifeSciences Directors, Officers Face 100% Lock-Up to 2027 - Stock Titan
Greenwich LifeSciences (GLSI) Expected to Post Earnings on Thursday - marketbeat.com
GLSI|Greenwich Lifesciences Inc|Price:13.400|Chg%:-0.100 - TradingKey
Understanding the Setup: (GLSI) and Scalable Risk - Stock Traders Daily
Form 4 Greenwich Lifesciences Inc For: 30 July By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $29,555 in stock By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $29,555 in stock - Investing.com
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares By Investing.com - Investing.com UK
Form 4 Greenwich Lifesciences Inc For: 29 July By Investing.com - Investing.com Canada
Greenwich LifeSciences, Inc. (GLSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Purchases 2,500 Shares - marketbeat.com
Greenwich Lifesciences Inc (GLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GLSI|Greenwich Lifesciences Inc|Price:13.470|Chg%:+0.490 - TradingKey
Form 4 Greenwich Lifesciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO buys $47,018 in company stock By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO buys $47,018 in company stock - Investing.com
Greenwich LifeSciences (NASDAQ: GLSI) CEO adds 3,600 shares in open-market buys - Stock Titan
Greenwich LifeSciences, Inc. Revenue Breakdown – NASDAQ:GLSI - TradingView
Greenwich Lifesciences Inc (GLSI) Cash Flow - TradingKey
TradingKey - TradingKey
Greenwich Lifesciences Inc (GLSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Greenwich Lifesciences Inc (GLSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Greenwich Lifesciences Inc (GLSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Greenwich Lifesciences Inc (GLSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Greenwich Lifesciences Inc (GLSI) Institutional Confidence - TradingKey
Greenwich Lifesciences Inc (GLSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Greenwich LifeSciences adds up to 10 UK trial sites - grafa.com
Greenwich LifeSciences gains UK approval for breast cancer trial By Investing.com - Investing.com South Africa
Greenwich LifeSciences Gets UK Clearance to Expand Breast Cancer Trial - Moomoo
Greenwich LifeSciences gains UK approval for breast cancer trial - Investing.com
Greenwich LifeSciences secures regulatory approval to expand FLAMINGO-01 trial into United Kingdom - Traders Union
Greenwich LifeSciences Announces UK Regulatory Approval to Expand Phase III FLAMINGO-01 Breast Cancer Trial - Quiver Quantitative
Greenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom - The Manila Times
UK approval could add 5-10 sites to Greenwich LifeSciences trial - Stock Titan
Greenwich Lifesciences Announces Approval To Expand FLAMINGO-01 Into The United Kingdom - TradingView
Greenwich LifeSciences: Building Pivotal Trial Momentum, But Still Not Moving The Needle For Me - Seeking Alpha
Greenwich LifeSciences expands Phase III breast cancer trial - grafa.com
Why is Greenwich LifeSciences stock rallying today? By Investing.com - Investing.com Canada
Greenwich LifeSciences updates phase III breast cancer trial design By Investing.com - Investing.com South Africa
Greenwich LifeSciences updates phase III breast cancer trial design - Investing.com
Greenwich LifeSciences Updates FLAMINGO-01 Phase III Trial Design, Enrollment and Financial Outlook - Quiver Quantitative
Greenwich trial opens enrollment to patients representing about 55% of population - Stock Titan
Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):